Clinical Trial Update: The REVIVE Pivotal Study [NA]

View source ↗

Summary

The REVIVE pivotal study sponsored by Ryme Medical, Inc. is currently not yet recruiting for COPD and COPD exacerbations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Ryme Medical, Inc. | Conditions: COPD (Chronic Obstructive Pulmonary Disease), COPD Exacerbations | NA | Status: NOT_YET_RECRUITING